|
TW460460B
(en)
|
1997-11-04 |
2001-10-21 |
Chugai Pharmaceutical Co Ltd |
Heterocyclic compounds having NOS inhibitory activities
|
|
AU759449C
(en)
|
1998-04-09 |
2003-10-30 |
Meiji Seika Pharma Co.,Ltd. |
Aminopiperidine derivatives as integrin alpha v beta 3 antagonists
|
|
ATE324362T1
(de)
|
1998-05-25 |
2006-05-15 |
Santen Pharmaceutical Co Ltd |
Neue vinylbenzolderivate
|
|
GB9818641D0
(en)
*
|
1998-08-26 |
1998-10-21 |
Rh Ne Poulenc Rorer Limited |
Chemical compounds
|
|
US6677360B2
(en)
|
1998-12-16 |
2004-01-13 |
Bayer Aktiengesellschaft |
Biphenyl and biphenyl-analogous compounds as integrin antagonists
|
|
US6420396B1
(en)
|
1998-12-16 |
2002-07-16 |
Beiersdorf Ag |
Biphenyl and biphenyl-analogous compounds as integrin antagonists
|
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
KR20010109275A
(ko)
|
1998-12-23 |
2001-12-08 |
로저 에이. 윌리암스 |
종양치료의 병용치료로서 사이클로옥시게나제-2 억제제와기질 금속단백분해효소 억제제를 사용하는 방법
|
|
US6291503B1
(en)
|
1999-01-15 |
2001-09-18 |
Bayer Aktiengesellschaft |
β-phenylalanine derivatives as integrin antagonists
|
|
AU6315300A
(en)
*
|
1999-07-26 |
2001-02-13 |
Shionogi & Co., Ltd. |
Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
|
|
US6750219B1
(en)
|
1999-08-05 |
2004-06-15 |
Meiji Seika Kaisha, Ltd. |
Ω-amino-α-hydroxycarboxylic acid derivatives having integrin ανβ3 antagonistic activity
|
|
US20050059669A1
(en)
*
|
1999-10-08 |
2005-03-17 |
Keiichi Ajito |
M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity
|
|
CA2398186A1
(en)
*
|
2000-01-25 |
2001-08-02 |
Mitsuhiro Abe |
Therapeutic agent for reperfusion injury comprising integrin .alpha.v.beta.3 antagonists
|
|
CN100356979C
(zh)
*
|
2000-02-03 |
2007-12-26 |
卫材R&D管理有限公司 |
整联蛋白表达抑制剂
|
|
JP2004525069A
(ja)
|
2000-06-15 |
2004-08-19 |
ファルマシア・コーポレーション |
インテグリン受容体アンタゴニストとしてのシクロアルキルアルカン酸
|
|
US6933304B2
(en)
|
2000-06-15 |
2005-08-23 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists
|
|
US20040043988A1
(en)
*
|
2001-06-15 |
2004-03-04 |
Khanna Ish Kurmar |
Cycloalkyl alkanoic acids as intergrin receptor antagonists
|
|
WO2003059251A2
(en)
|
2001-10-22 |
2003-07-24 |
The Scripps Research Institute |
Antibody targeting compounds
|
|
WO2003075741A2
(en)
*
|
2002-03-04 |
2003-09-18 |
Medimmune, Inc. |
METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
|
|
JP2005533001A
(ja)
*
|
2002-03-04 |
2005-11-04 |
メディミューン,インコーポレーテッド |
インテグリンαvβ3アンタゴニストを他の物質と併用投与する癌の予防または治療方法
|
|
JP2006516144A
(ja)
*
|
2002-12-20 |
2006-06-22 |
ファルマシア・コーポレーション |
インテグリン受容体アンタゴニスト誘導体としてのチアゾール化合物
|
|
CA2507699A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists
|
|
BR0316875A
(pt)
*
|
2002-12-20 |
2005-10-25 |
Pharmacia Corp |
Compostos de pirazol como derivados antagonistas receptores da integrina, sua composição farmacêutica e respectivo uso
|
|
US20040176272A1
(en)
*
|
2003-01-30 |
2004-09-09 |
Medimmune, Inc. |
Uses of integrin alphavbeta3 antagonists
|
|
UA87854C2
(en)
|
2004-06-07 |
2009-08-25 |
Мерк Энд Ко., Инк. |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
|
|
TWI396543B
(zh)
|
2005-05-12 |
2013-05-21 |
Sankyo Co |
取代丙烯醯胺衍生物及含有它之醫藥組成物
|
|
CA2630415A1
(en)
*
|
2005-10-20 |
2007-04-26 |
The Scripps Research Institute |
Fc labeling for immunostaining and immunotargeting
|
|
JP2008231088A
(ja)
*
|
2006-10-30 |
2008-10-02 |
Santen Pharmaceut Co Ltd |
1,4−ベンゾオキサジン−3−オン骨格を有する新規化合物
|
|
WO2008053863A1
(en)
*
|
2006-10-30 |
2008-05-08 |
Santen Pharmaceutical Co., Ltd. |
Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton
|
|
DK2222636T3
(da)
|
2007-12-21 |
2013-06-03 |
Ligand Pharm Inc |
Selektive androgenreceptormodulatorer (SARMS) og anvendelser deraf
|
|
US8518927B2
(en)
|
2009-02-10 |
2013-08-27 |
The Scripps Research Institute |
Chemically programmed vaccination
|
|
US8716226B2
(en)
|
2012-07-18 |
2014-05-06 |
Saint Louis University |
3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
|
|
CN104640857B
(zh)
|
2012-07-18 |
2017-07-04 |
圣路易斯大学 |
作为整合素拮抗剂的β氨基酸衍生物
|
|
BR112016027778A2
(pt)
|
2014-05-30 |
2017-08-15 |
Pfizer |
Usos de derivados de carbonitrila, sua combinação e sua composição farmacêutica
|
|
CN105272888B
(zh)
*
|
2014-06-24 |
2018-03-27 |
中国科学院上海药物研究所 |
双芳基烯烷酸类化合物及其制备方法和用途
|
|
RU2729518C2
(ru)
|
2015-12-30 |
2020-08-07 |
Сент-Луис Юниверсити |
Мета-азациклические производные аминобензойной кислоты в качестве антагонистов пан-интегрина
|
|
CN114096522A
(zh)
|
2019-04-19 |
2022-02-25 |
利亘制药公司 |
化合物的晶型和制备化合物的晶型的方法
|
|
WO2023275715A1
(en)
|
2021-06-30 |
2023-01-05 |
Pfizer Inc. |
Metabolites of selective androgen receptor modulators
|